EUVIMEDEUVIMED entdecken
Crossref

Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation

Xiangjie Luo, Hui Xiong, Yuhang Jiang, Yifan Fan, Cuicui Zuo, Dongxia Chen, Limin Chen, Hongyu Lin iD, Jinhao Gao iD

Bioconjugate Chemistry · 19.07.2023 · 34 (7) · 1316-1326

DOI: 10.1021/acs.bioconjchem.3c00239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 18.06.2023. Verfasst von Xiangjie Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Chemical Biology, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemica…. Hauptthemen laut MEDLINE: Inflammation, Macrophages. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Youth Innovation Foundation of Xiamen, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation-related diseases affect large populations of people in the world and cause substantial healthcare burdens, which results in significant costs in time, material, and labor. Preventing or relieving uncontrolled inflammation is critical for the treatment of these diseases. Herein, we report a new strategy for alleviating inflammation by macrophage reprogramming via targeted reactive oxygen species (ROS) scavenging and cyclooxygenase-2 (COX-2) downregulation. As a proof of concept, we synthesize a multifunctional compound named MCI containing a mannose-based macrophage targeting moiety, an indomethacin (IMC)-based segment for inhibiting COX-2, and a caffeic acid (CAF)-based section for ROS clearance. As revealed by a series of in vitro experiments, MCI could significantly attenuate the expression of COX-2 and the level of ROS, leading to M1 to M2 macrophage reprogramming, as evidenced by the reduction and the elevation in the levels of pro-inflammatory M1 markers and anti-inflammatory M2 markers, respectively. Furthermore, in vivo experiments show MCI's promising therapeutic effects on rheumatoid arthritis (RA). Our work illustrates the success of targeted macrophage reprogramming for inflammation alleviation, which sheds light on the development of new anti-inflammatory drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationMacrophagesHumansCyclooxygenase 2Reactive Oxygen SpeciesDown-Regulation

Substanzen

Cyclooxygenase 2Reactive Oxygen Species

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Chemical Biology, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen Unive…

ORCID-Profile: Hongyu Lin, Jinhao Gao

Förderung

  • Youth Innovation Foundation of Xiamen
  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China

Zitieren

APA

Luo, X., Xiong, H., Jiang, Y., Fan, Y., Zuo, C., Chen, D., Chen, L., Lin, H., & Gao, J. (2023). Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation. Bioconjugate Chemistry, 34(7), 1316-1326. https://doi.org/10.1021/acs.bioconjchem.3c00239

Vancouver

Luo X, Xiong H, Jiang Y, Fan Y, Zuo C, Chen D, et al. Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation. Bioconjugate Chemistry. 2023;34(7):1316-1326. doi:10.1021/acs.bioconjchem.3c00239

BibTeX
@article{Luo2023,
  author = {Luo, Xiangjie and Xiong, Hui and Jiang, Yuhang and Fan, Yifan and Zuo, Cuicui and Chen, Dongxia and Chen, Limin and Lin, Hongyu and Gao, Jinhao},
  title = {Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation},
  journal = {Bioconjugate Chemistry},
  year = {2023},
  volume = {34},
  number = {7},
  pages = {1316--1326},
  doi = {10.1021/acs.bioconjchem.3c00239}
}
Kostenlos starten →